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Abstract 15 
Introduction: IL-6 has been ascribed both positive and negative roles in the context of 16 
exercise and training. The dichotomous nature of IL-6 signalling appears to be determined by 17 
the respective concentration of its receptors (both membrane-bound (IL-6R) and soluble (sIL-18 
6R) forms). The purpose of the present study was to investigate the response of sIL-6R to 19 
long-term training, and to investigate the relationship between sIL-6R, self-reported measures 20 
of wellbeing, and upper respiratory illness symptoms (URS) in highly-trained endurance 21 
athletes. Methods: Twenty-nine athletes provided resting blood samples, and completed 22 
wellbeing and illness monitoring questionnaires, on a weekly basis for a period of 18 weeks 23 
during a winter training block. Results: URS were not correlated to concentrations of sIL-6R 24 
or cortisol, but there was a non-significant trend (P=0.08) for the most illness-prone athletes 25 
(as defined by self-reported illness questionnaire data) to exhibit higher average sIL-6R 26 
concentrations compared to the least ill (23.7±4.3 Vs 20.1±3.8 ng/ml). Concentrations of sIL-27 
6R were positively correlated to subjective measures of stress (r=0.64, P=0.004) and mood 28 
(r=0.49, P=0.02), but were negatively correlated to sleep quality (r=-0.43, P=0.05) and 29 
cortisol concentration (r=-0.17, P=0.04). In a sub-group of 10 athletes, weekly training 30 
distance was quantified by coaching staff, and this negatively correlated with sIL-6R in the 31 
following week (r=-0.74, P<0.005). Conclusion: The findings of the current study suggest 32 
that sIL-6R is responsive to prolonged periods of exercise training, with sIL-6R levels 33 
varying related to the volume of training performed in the preceding week. Importantly, our 34 
data indicate that changes in sIL-6R levels could be linked to common symptoms of 35 
overreaching such as high levels of stress, and/or depressed mood.  36 
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 39 
Introduction  40 
IL-6 is a pleiotropic cytokine that has multiple functions throughout the body, and which has 41 
been ascribed both positive and negative roles in terms of health (29, 40); in the context of 42 
exercise IL-6 exerts anti-inflammatory effects primarily by causing the induction of anti-43 
inflammatory mediators such as IL-10, IL-1Ra and cortisol (39). As such, exercise-induced 44 
increases in IL-6 are associated with a transient anti-inflammatory state that, if repeated, can 45 
lead to health benefits via the reduction of chronic inflammation (11, 29). Conversely, in the 46 
context of infection, sepsis or trauma IL-6 can have a pro-inflammatory role with pyrogenic 47 
functions, and indeed IL-6 administration in humans has been shown to induce symptoms of 48 
sickness and fever (34). In addition, chronically elevated levels of IL-6 are associated with 49 
the development of numerous diseases of an inflammatory aetiology such as type 2 diabetes, 50 
rheumatoid arthritis (40) and clinical depression (8). 51 
 52 
The dichotomous nature of IL-6 signalling appears to be related to the fact that it has two 53 
types of receptor; a membrane bound (IL-6R) and a soluble (sIL-6R) receptor, each of which 54 
is associated with distinct signalling pathways termed ‘classical’ and ‘trans-signalling’ 55 
respectively (17). Classical signalling is limited to cells and organs that possess IL-6R such 56 
as hepatocytes and leukocytes (17), the brain (37) and skeletal muscle (19). In contrast sIL-57 
6R is present in the circulation and allows cells that do not possess IL-6R to respond to IL-6 58 
via the process of trans-signalling (i.e. sIL-6R interacting with the ubiquitously-expressed 59 
cell-surface receptor gp130 in order to trigger intracellular responses within target cells (16)). 60 
Trans-signalling through sIL-6R is predominantly pro-inflammatory and appears largely 61 
responsible for the negative pathological effects associated with IL-6 (18). 62 
 63 
It has previously been postulated that IL-6 might also play a role in the development of 64 
overtraining (35) and immunosuppression (10), both of which are associated with the 65 
increased rate of upper respiratory illnesses (URI), and/or reporting of upper respiratory 66 
symptoms (URS) by athletes undertaking high volumes of training. While there is some 67 
convincing evidence that supports the role of IL-6 with common aspects of overreaching such 68 
as increased perception of training overload, a depressed mood (23), fatigue (31, 33) and 69 
decreased performance (34), there is less empirical evidence to support the role of IL-6 in the 70 
increased rate of URI in athletes. There is also debate over whether the symptoms associated 71 
with URIs are purely due to infections or are in fact a reflection of inflammatory factors that 72 
could be induced by exercise (41). In the case of IL-6, it may be difficult to ascertain whether 73 
an increase in IL-6 may increase susceptibility to a possible future infection, or whether such 74 
an increase may actually be a response to an infection to which the body is now responding 75 
via an inflammatory response. While some studies have reported no elevation in resting IL-6 76 
levels in response to intensified training in athletes (16), others have reported greater 77 
exercise-induced increases in IL-6 in URI-prone athletes and have suggested that greater 78 
increases in IL-6 in illness-prone athletes could be due to excessive inflammatory responses 79 
(3).  80 
 81 
Importantly, several studies have suggested that some of the negative, pro-inflammatory 82 
effects of IL-6 signalling could be explained by differences in sensitivity to IL-6 that are 83 
mediated by changes in the relative concentration of sIL-6R (32). In contrast to IL-6, only a 84 
limited number of studies have reported the effect of exercise on the circulating concentration 85 
of sIL-6R. Small increases in sIL-6R (approximately 10%) have been reported immediately 86 
following aerobic exercise (13, 14, 21, 42); however, other studies have reported no change 87 
(14, 28). This contradictory evidence and small number of studies make it difficult to reach a 88 
clear conclusion as to how sIL-6R responds to acute endurance exercise. However, it does 89 
appear that the circulating concentration of sIL-6R is significantly reduced following a period 90 
of prolonged exercise training (1, 44), and a recent study reported a significant reduction in 91 
sIL-6R following only 2 weeks of high intensity training (20). To our knowledge no study 92 
has yet investigated changes in sIL-6R throughout prolonged training programmes, but given 93 
the apparent importance of sIL-6R signalling to the negative effects of IL-6 it is important to 94 
gain an improved understanding of how exercise can modulate sIL-6R during prolonged 95 
periods of exercise training.  96 
 97 
Therefore, the aims of the current study were: a) to investigate circulating sIL-6R responses 98 
to long-term training in endurance trained athletes; and b) to investigate the relationship 99 
between sIL-6R, subjective measures of wellbeing and the reported rate of URS over the 100 
course of an 18-week winter training period. 101 
 102 
 103 
Methods  104 
Participants 105 
Twenty-nine (16 male; 13 female) endurance-trained athletes volunteered to participate in the 106 
study and provided informed consent prior to taking part. The participants consisted of four 107 
separate squads including triathletes (n=6), swimmers (two squads, n=10 and n=5), and 108 
rowers (n=8), all of which were receiving physiological support from Sport Wales (the 109 
organisation responsible for sports science support services to elite athletes in Wales). All 110 
athletes within the study were typically training for approximately 20 hours per week with 111 
the aim of competing to the highest level, including competing at a national and/or 112 
international standard. Ethical approval was obtained from the Cardiff Metropolitan 113 
University School of Sport Ethics committee and all procedures conformed to the declaration 114 
of Helsinki. 115 
 116 
Study Design 117 
All athletes were studied for an 18-week winter training period (October 2013-February 118 
2014), which took place after a period of relative rest following the end of the previous 119 
competitive season. Throughout the study, athletes carried out their normal training regimens 120 
as directed by their individual coaching staff. All data were collected at the training location 121 
of each squad; sample donation was considered part of their normal routine and no aspect of 122 
training was altered as a result of their taking part in the study. Athletes provided blood 123 
samples in a non-fasted state, and completed an illness and wellbeing questionnaire on a 124 
weekly basis. Data was not collected during weeks 15 and 16 of the study as these dates 125 
coincided with a period of reduced training volume and also fell on Christmas Day and New 126 
Year’s Day (please see Figure 1 for a schematic illustration of the study design). 127 
 128 
In order to avoid the acute effects of individual exercise bouts, these measurements were 129 
obtained a minimum of 24hrs after the most recent training session. For each squad, data 130 
collection took place at the same time of day prior to training on the same day of the week 131 
(individual squads were tested on different days of the week in order to comply with their 132 
normal training routine). The Triathletes and Swimmers B provided blood samples prior to 133 
their morning training sessions at 6:00 whereas the Rowers and Swimmers A provided 134 
samples in the afternoon between 14:00-16:00.  While athletes from 4 separate squads were 135 
used, the entire study was carried out over the same time scale to avoid seasonal differences 136 
in respiratory illness.   137 
 138 
Capillary blood was used to determine the plasma concentrations of sIL-6R and cortisol, 139 
which were compared with self-reported measures of illness and wellbeing. The 140 
concentration of sIL-6R was measured every week, while cortisol was measured every 141 
month. In a sub group of 10 athletes, all of whom were from the same squad of swimmers 142 
(swimmers A), weekly prescribed training distance was correlated with sIL-6R and cortisol 143 
concentrations measured during the following week in order to ascertain how these 144 
physiological variables responded to training on a weekly basis. Similar to the methods 145 
described by Purge, Jürimäe and Jürimäe (2006), weekly training volumes were calculated 146 
based on the sum of the distance prescribed by the coaching staff in each training session, and 147 
also athletes’ individual daily training diaries (30).  148 
 149 
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 152 
Illness and wellbeing questionnaire  153 
The illness and wellbeing questionnaire employed throughout the present study was a 9-point 154 
questionnaire used internally at Sport Wales to monitor self-reported aspects of wellbeing 155 
and illness. The questionnaire is a modified version of the wellbeing questionnaire utilised in 156 
the study of McLean et al., 2010 (24); similar questionnaires have good reliability and 157 
validity, and have been shown to be sensitive to fatigue in Professional Rugby League (6). 158 
Questionnaire data was analysed alongside self-reported measures of training load; such data 159 
are routinely used with elite athletes and have been repeatedly shown to be sensitive to 160 
training overload in a number of sports (22, 25).  161 
 162 
Athletes were asked to rate on a 5-point scale the following categories: fatigue, muscle 163 
soreness, stress, mood, motivation to train and quality of sleep. The questionnaire also 164 
required athletes to indicate the average number of hours of sleep per night in the last week. 165 
Prior to completing the questionnaire, athletes were provided with a full explanation of each 166 
question. With regards to illness, athletes were asked to indicate the number of days in the 167 
past week where they had suffered symptoms of upper respiratory illness, the severity of 168 
these symptoms and to what degree this had affected their training. This method was chosen 169 
in light of recent evidence suggesting that a greater percentage of URI are reported when 170 
using a self-reported questionnaire than when athletes are required to report their symptoms 171 
to affiliated medical staff (5). However, it should be noted that this method does not allow for 172 
the clinical determination of pathogenic cause of any illness symptoms, and the physical 173 
presence of an infection could not be verified; as a result the term ‘upper respiratory tract 174 
symptoms’ (URS) rather than URTI or URI was used throughout this study. Athletes were 175 
not vaccinated against influenza as part of the study.  176 
 177 
sIL-6R and cortisol 178 
Capillary blood samples were collected from the fingertip in 200 μl heparinized microvette 179 
capillary blood collection tubes (Sarstedt, Germany) as previously described in more detail 180 
(4). Blood samples were fractionated by centrifugation (10 min; 3,000 x G), and the resulting 181 
plasma was aliquoted and stored at -80 °C until analysis. Circulating sIL-6R and cortisol 182 
concentrations were measured using enzyme-linked immunosorbent assays (ELISA) (R&D 183 
Systems Ltd., Abingdon, UK). All additional materials and chemical reagents were purchased 184 
from R&D systems, and the assays were carried out in accordance with the manufacturer’s 185 
instructions. Plasma samples were diluted at 1:100 with a commercially available diluent 186 
(DY997, R&D Systems Ltd) prior to analysis of sIL-6R, and 1:20 prior to analysis of 187 
cortisol, in order to produce concentrations that were within the dynamic range of the assay. 188 
Both assays had been previously validated for use with plasma samples using standard spike 189 
recovery and linearity procedures (data not shown). The sIL-R assay had an intra-assay CV 190 
of 1.5 ± 0.7% across a range of 1.56-100 ng/ml. The cortisol assay had an intra-assay CV of 191 
7.3 ± 3.9% across a range of 0.156-10 ng/ml. The intra-assay CVs were calculated from the 192 
duplicate readings obtained during each experiment. Protein concentrations were determined 193 
in relation to a four-parameter standard curve (GraphPad Prism, San Diego California, USA). 194 
 195 
Statistical Analysis 196 
A one-way ANOVA was used to analyse differences in mean sIL-6R and cortisol values 197 
between each squad of athletes. A Bonferroni post hoc was conducted to analyse where 198 
differences existed. Pearson product moment correlation was used to investigate the 199 
relationship between sIL-6R or cortisol, and the volume of training performed in the 200 
preceding week. Correlations were conducted on pooled data from all individuals within a 201 
subset of the total cohort (a single squad of 10 swimmers) for each training week. 202 
 203 
A repeated-measures stepwise regression model was used to assess the relationships between 204 
physiological measures (i.e. sIL-6R and cortisol levels), self-reported wellbeing, and illness 205 
measures over the entire study using data from all groups, with analyses being conducted on 206 
pooled data from all individuals for each training week. In studies of this type there is 207 
potential for data dropout due to logistical reasons or personal circumstance, and so previous 208 
researchers have recommended regression modelling when studying URI risk in athletes, as it 209 
has been reported to be robust when data are missing (12).  Athletes were categorised into 210 
most and least illness prone (upper and lower quartile for illness index), and a Mann Whitney 211 
U-test was used to investigate differences between the most and least illness-prone athletes. 212 
For the purpose of regression analysis, cortisol concentrations were expressed as an 213 
individual’s relative cortisol concentration, defined here as the percentage difference 214 
compared to the average value for the individual, this allows for a fair comparison of the 215 
relative stress for the individual (26). All analysis was conducted in SPSS version 20.0. 216 
Statistical significance was set at P≤0.05. 217 
Results 218 
Physiological responses 219 
Over the entirety of the study a total of 293 capillary blood samples were analysed with a 220 
mean sIL-6R of 21.0 ± 4.6 ng/ml. There was no significant difference in mean sIL-6R 221 
between squads of athletes (Triathletes= 18.7 ± 4.6 ng/ml, Rowers= 22.3 ± 4.5 ng/ml, 222 
Swimmers A= 22.3 ± 3.3 ng/ml, Swimmers B= 20.4 ± 5.2 ng/ml Figure 2A). A significant 223 
difference was found for resting cortisol concentration between groups (P<0.001). Triathletes 224 
had significantly higher resting cortisol concentrations than Swimmers A and Rowers (mean 225 
difference =43.4 and 44.4 pg/ml) as did Swimmers B (mean difference =53.9 and 55.2 pg/ml) 226 
(Figure. 2B). In a subgroup of 10 swimmers (Swimmers B), prescribed training mileage was 227 
64.6 ± 21.1km/wk (range=19.6-89km/wk), and sIL-6R levels on any given week were 228 
negatively correlated with the volume of training prescribed in the previous week (r=-0.74, 229 
P<0.005) (Figures 3A and 3B), while cortisol levels (as analysed on the same basis) showed a 230 
positive correlation with training volume (r=0.89, P=0.045) (Figures 4A and 4B). Finally, 231 
sIL-6R was negatively correlated with cortisol concentration (r=-0.17, P=0.04). 232 
 233 
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 238 
Illness and wellbeing monitoring 239 
All athletes reported experiencing URS at some point throughout the study. Athletes reported 240 
URS for an average of 17.4 ± 8.5 days (range 1-40) throughout the entire study, while the 241 
number of athletes reporting URS per week ranged from 5-12 (mean ± SD = 8.4 ± 2.6). 242 
Based upon regression analysis across the entire cohort, neither the absolute or relative 243 
concentration of sIL-6R nor the relative cortisol concentration was related to the number of 244 
days with illness symptoms or the severity of these symptoms. However, there was a non-245 
significant trend (P=0.08) for a higher average sIL-6R concentration in the most ill quartile 246 
compared to the least ill quartile of athletes (23.7 ± 4.3 Vs 20.1 ± 3.8 ng/ml).  247 
 248 
With regard to subjective measures of wellbeing, circulating concentrations of sIL-6R were 249 
positively correlated to perceived stress (r=0.64, P=0.004) and worse mood (r=0.49, P=0.02) 250 
but negatively correlated to worse sleep quality (r=-0.43, P=0.05). Finally, the number of 251 
days with illness symptoms was positively correlated to subjective measures of fatigue 252 
(r=0.48, P=0.02), worse sleep quality (r=0.61, P=0.007), and the degree to which training was 253 
affected by illness (r=0.78, P<0.0001). No significant correlations were observed between 254 
measures of wellbeing and resting cortisol concentrations. 255 
Discussion 256 
The novel findings of this study were that changes in resting sIL-6R concentration were 257 
observed during a prolonged period of exercise training, and specifically that resting sIL-6R 258 
levels in any given week appear to be inversely related to the volume of training performed in 259 
the previous week. Moreover, resting sIL-6R levels were related to several self-reported 260 
measures of wellbeing, supporting previous suggestions of the central effects of IL-6 261 
signalling and further highlighting the potential role of ‘trans-signalling’ via sIL-6R in these 262 
processes. These findings suggest the important prospect that differences in the concentration 263 
of sIL-6R could be linked to increases in perceived stress, decreased mood, and impaired 264 
quality of sleep in athletes. When taken together it is possible that sIL-6R could represent a 265 
marker of training stress that is sensitive of changes on weekly basis. 266 
 267 
In accordance with these findings, two previous studies have reported significant reductions 268 
in the circulating concentration of sIL-6R following a prolonged exercise training programme 269 
in post-menopausal women (24.5 ± 5.2 to 22.4 ± 5.1 ng/ml) (44) and chronic heart failure 270 
patients (34.0 ± 3.0 to 29.2 ± 3.0 ng/ml) (1). The average concentration of sIL-6R in the 271 
present study (21.0 ± 4.6 ng/ml) appears lower than that reported in the two aforementioned 272 
studies; however, given that these studies reported significant reductions in sIL-6R following 273 
chronic training it is perhaps unsurprising that athletes display a relatively lower 274 
concentration than their non-athletic counterparts. With regard to resting cortisol 275 
concentrations, we observed a significant relationship with training volume, an observation 276 
that has been observed in previous longitudinal studies of highly trained endurance athletes 277 
(30). As such the physiological responses of the athletes in this study appear normal in the 278 
context of other literature. Also in agreement with previous literature (43), it was observed 279 
that the two squads providing samples early in the morning (Triathletes and Swimmers B) 280 
displayed significantly higher concentrations of cortisol than those from squads where 281 
samples were obtained in the afternoon (Rowers and Swimmers A) (Figure 2B). Interestingly 282 
this apparent diurnal effect was not evident in sIL-6R, the concentrations of which were 283 
negatively associated with perceived sleep quality. These results are in agreement with recent 284 
research suggesting that sleep increases the concentration of sIL-6R (7). While the limitations 285 
of subjective measurement of sleep should be acknowledged, this is an interesting finding 286 
and represents another example of the complex differences between IL-6 and sIL-6R. 287 
Specifically, sleep disturbance is reported to be associated with increased IL-6 (23) but 288 
reduced sIL-6R (7) which in the case of sIL-6R demonstrates a different relationship to those 289 
observed for other measures of wellbeing. We suggest that this is an area that warrants 290 
comprehensive further investigation in a more controlled environment. 291 
 292 
It should be stressed that this is the first study to longitudinally monitor the concentration of 293 
sIL-6R in highly trained athletes during a prolonged period of training, and a novel finding 294 
was that sIL-6R concentrations were negatively correlated to the volume of training 295 
performed in the previous week (r=-0.74, P<0.005) (Figure 3B). Another novel finding in this 296 
study was that higher levels of sIL-6R were associated with higher reported levels of stress 297 
(r=0.64, P=0.004) and worse mood (r=0.49, P=0.02). These data are in accordance with the 298 
apparent consensus that clinical depression can have an inflammatory aetiology (8), and that 299 
psychological mood state can be negatively affected by an up regulation in pro-inflammatory 300 
cytokines (22, 23). Given that self-reported measures of stress and mood are routinely 301 
reported as worse in overtrained athletes (15), and the fact that sIL-6R was not only related to 302 
these measures but also to weekly training distance, it appears plausible that high levels of 303 
sIL-6R could predispose athletes to some of the regular symptoms associated with 304 
overtraining and that sIL-6R may be sensitive measure of the relative stress of training 305 
performed on a weekly basis. 306 
 307 
In the current study, athletes reported illness symptoms for an average of 17.4 ± 8.5 days 308 
throughout the study (18 weeks) with an average of approximately eight athletes (or ~30% of 309 
the entire cohort) reporting symptoms during each week. There are discrepancies among 310 
previous similar longitudinal studies with some reporting fewer illnesses (26) and others a 311 
greater number (9) than the current study. While this fact makes it difficult to make 312 
comparisons to other studies, reported illness rates in the present study appear similar to those 313 
of a study employing a similar method of subjective reporting of illness symptoms (5). In the 314 
current study, the number of days with illness symptoms was significantly correlated to 315 
subjective ratings of fatigue at rest, perceived sleep quality, and the degree to which training 316 
had been affected by illness. These data indicate that athletes were negatively impacted by 317 
URS, and therefore support the notion that illness could negatively impact upon either 318 
training performance or the ability to maintain a high training volume. 319 
 320 
It has previously been suggested that the increased rates of URS experienced by some 321 
athletes could be due to an excessive pro-inflammatory response as indicated by a higher IL-322 
6 response to exercise (3). As such it was hypothesised that a higher sIL-6R might predispose 323 
athletes to a greater frequency of URS. In the current study sIL-6R tended to be higher for the 324 
most illness-prone compared to the least illness-prone athletes (upper Vs lower quartile of 325 
days with illness symptoms), although the difference was not significant (P=0.08). It is 326 
possible that with a larger sample size or a more prolonged period of monitoring a significant 327 
difference may have been found. However, a further complicating factor is that sIL-6R is 328 
likely only of relevance when URS are inflammatory in origin; current research estimates that 329 
this is the case in approximately 30-40% of incidents where URS are reported (2). Therefore, 330 
while differences in the concentration of sIL-6R may play a part in the higher rate of URS 331 
experienced by some athletes, it should be noted that sIL-6R is unlikely to be the sole 332 
predictor of URS. 333 
 334 
Given the pro-inflammatory role ascribed to sIL-6R and its association with a number of 335 
inflammatory diseases (36), it is plausible that exercise-induced reductions in sIL-6R could 336 
be partly responsible for certain exercise-induced health benefits, especially in people with 337 
inflammatory conditions. This contention is supported by studies reporting that blockade of 338 
IL-6 signalling, via tocilizumab, significantly reduces disease severity in inflammatory 339 
conditions such as rheumatoid arthritis and Castleman syndrome (27). More recent studies 340 
have identified selective blockade of sIL-6R as a potential therapeutic target for 341 
pharmacological intervention, and have shown that such a blockade reduces atherosclerotic 342 
plaque development in a mouse model of atherosclerosis (38). While the present study does 343 
not provide any mechanistic insight into the mechanisms of how sIL-6R concentration is 344 
regulated, it does shed some light onto the pattern of regulation in the context of exercise 345 
training. Given this pattern of regulation, our study supports the notion that the anti-346 
inflammatory effects of exercise are related to the volume of exercise performed. However, 347 
caution should be applied when interpreting the data from this study given that the results are 348 
from highly trained endurance athletes, and hence the responses seen here may not 349 
necessarily be representative of what might be seen in untrained or indeed diseased 350 
populations. Nevertheless, we recommend that future work investigating exercise related 351 
anti-inflammatory effects should include sIL-6R, and specifically should further examine 352 
exercise-induced changes in sIL-6R and their relationship to chronic inflammatory diseases.  353 
 354 
In summary, the results of this study provide further evidence that sIL-6R is reduced by 355 
exercise training, and demonstrate for the first time that this response is related to the volume 356 
of training performed. Moreover, given that sIL-6R levels were related to psychological 357 
measures of stress and mood, and appeared to be higher in athletes reporting the most URS, 358 
this study provides evidence that IL-6 trans-signalling via sIL-6R may play a role in some 359 
aspects of overreaching and that its assessment for quantifying the effects of prior 360 
training should be considered, especially in athletes where high volumes are 361 
undertaken. 362 
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 496 
Figure Legends 497 
Figure 1. Schematic of the sampling procedure and study design. 498 
Figure 2: Mean sIL-6R (A) and cortisol (B) for each squad of athletes for the entire 499 
study. *= Significantly different to Swimmers A and Rowers; #= Significantly different to 500 
Triathletes and Swimmers B (P<0.05). 501 
Figure 3: Prescribed weekly training distance and mean sIL-6R on a weekly basis for a 502 
single squad of 10 swimmers (A). The relationship between the prescribed weekly training 503 
distance and mean sIL-6R concentration in the following week for a squad of 10 swimmers, 504 
r=-0.74, P=0.005 (B).  505 
Figure 4: Prescribed weekly training distance and mean cortisol on a monthly basis for a 506 
single squad of 10 swimmers (A). The relationship between prescribed weekly training 507 
distance and mean cortisol concentration in the following week for a squad of 10 swimmers, 508 
(r=0.89, P=0.045) (B). 509 
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